XML 46 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option Activity
Stock options for the year ended December 31, 2016 under the Company’s plans are as follows:

   
Number of options
   
Weighted average exercise price
   
Weighted average remaining contractual term
(in years)
   
Aggregate intrinsic value
 
                         
Outstanding at January 1, 2016
   
856,986
     
7.75
     
3.28
   
$
6,157
 
Granted
   
281,800
     
11.68
                 
Exercised
   
(508,149
)
   
6.55
                 
Expired and forfeited
   
(6,200
)
   
10.33
                 
                                 
Outstanding at December 31, 2016
   
624,437
     
10.47
     
3.55
   
$
4,576
 
                                 
Vested and expected to vest at December 31, 2016
   
624,437
     
10.47
     
3.55
   
$
4,576
 
                                 
Exercisable at December 31, 2016
   
330,337
     
9.41
     
2.75
   
$
2,771
 
Schedule of RSUs
RSUs for the year ended December 31, 2016 under the Company’s 2013 Share Option Plan are as follows:

   
Number of RSUs
   
Weighted average remaining contractual term
(in years)
   
Aggregate intrinsic value
 
                   
Outstanding at January 1, 2016
   
15,500
     
0.1
   
$
231
 
Granted
   
216,300
                 
Vested
   
(37,500
)
               
Cancelled and forfeited
   
(1,150
)
               
                         
Outstanding at December 31, 2016
   
193,150
     
2.02
   
$
3,438
 
                         
Vested and expected to vest at December 31, 2016
   
193,150
     
2.02
   
$
3,438
Stock Options Under the Plans by Exercise Price
As of December 31, 2016, stock options under the 2013 Share Option Plan, as amended are as follows for the year ended December 31, 2016:

     
Options outstanding
at December 31, 2016
   
Options exercisable
at December 31, 2016
 
Exercise price
   
Number
outstanding
   
Weighted
average exercise
price
   
Weighted average remaining contractual life
   
Number
exercisable
   
Weighted average exercise price
   
Weighted
average remaining contractual life
 
$
         
$
   
In years
         
$
   
In years
 
                                       
2.56 - 4.86
     
50,587
     
3.28
     
1.76
     
50,587
     
3.28
     
1.76
 
5.17 - 8.60
     
70,750
     
6.49
     
2.16
     
70,750
     
6.49
     
2.16
 
10.49 – 14.52
     
503,100
     
11.75
     
3.93
     
209,000
     
11.88
     
3.19
 
                                                   
       
624,437
                     
330,337
                 
Departmental Allocation of Share-based Compensation Charge
The following table summarizes the departmental allocation of the Company's share-based compensation charges:

   
Year ended December 31,
 
   
2016 (*)
   
2015 (*)
   
2014
 
                   
Cost of revenues
 
$
118
   
$
33
   
$
12
 
Research and development, net
   
625
     
529
     
178
 
Selling and marketing, net
   
199
     
380
     
146
 
General and administrative
   
1,529
     
467
     
243
 
                         
   
$
2,471
   
$
1,409
   
$
579
 

(*)
Including $1,331 and $342 of compensation cost related to RSUs for the year ended December 31, 2016 and 2015, respectively.